Reply to: Selective history of radioactive iodine in medicine: Inexactitudes no longer

被引:0
作者
Marti, Jennifer L. [1 ]
Morris, Luc G. T. [2 ]
Ho, Allen S. [3 ]
机构
[1] Weill Cornell Med, Endocrine Surg, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, Head & Neck Serv, 1275 York Ave, New York, NY 10021 USA
[3] Cedars Sinai Med Ctr, Dept Surg, Los Angeles, CA 90048 USA
来源
EJSO | 2019年 / 45卷 / 04期
关键词
RAI;
D O I
10.1016/j.ejso.2018.08.025
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:713 / 714
页数:2
相关论文
共 6 条
[1]   The role of clinicians in determining radioactive iodine use for low-risk thyroid cancer [J].
Haymart, Megan R. ;
Banerjee, Mousumi ;
Yang, Di ;
Stewart, Andrew K. ;
Koenig, Ronald J. ;
Griggs, Jennifer J. .
CANCER, 2013, 119 (02) :259-265
[2]   Selective use of radioactive iodine (RAI) in thyroid cancer: No longer "one size fits all" [J].
Marti, J. L. ;
Morris, L. G. T. ;
Ho, A. S. .
EJSO, 2018, 44 (03) :348-356
[3]  
Tulchinsky M., PETITION RETRACT ART, DOI [10.1200/JC0.2017.75.0232, DOI 10.1200/JC0.2017.75.0232]
[4]  
Tulchinsky M., COMMUNICATION
[5]  
Tulchinsky M, 2018, 63 ANN M SW CHAPT SO
[6]   Re: Low-Dose Radioactive Iodine Ablation Is Sufficient in Patients With Small Papillary Thyroid Cancer Having Minor Extrathyroidal Extension and Central Lymph Node Metastasis (T3 N1a) [J].
Tulchinsky, Mark .
CLINICAL NUCLEAR MEDICINE, 2018, 43 (08) :630-630